Vericel Corp Ord (VCEL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.91B
Last updated: Nov 17, 2026 at 11:05 AM ET
Vericel Corp Ord (VCEL) Earnings: Report Dates and Results
Vericel Corp Ord (VCEL) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Vericel Corp Ord reported EPS of $0.27. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
VCEL has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 28.9% above the $0.45 reported for the quarter ended Dec 31, 2025.
VCEL Earnings Call
The latest VCEL earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 38 quarters below that had an estimate, VCEL beat 21, missed 12 and matched 5. Revenue for the quarter ended Sep 30, 2026 was $85.37M, up 26.5% from $67.50M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.27 | $0.02 | $0.02 - $0.10 | N/A | N/A | +170.0% | 5 | 1 up, 0 down | Nov 5, 2026 | $85.37M |
| Jun 30, 2026 | $0.04 | -$0.04 | -$0.06 - $0.00 | +200.00% | Beat | N/A | 6 | 0 up, 0 down | Jul 30, 2026 | $77.46M |
| Mar 31, 2026 | -$0.12 | -$0.16 | -$0.17 - -$0.14 | +25.00% | Beat | N/A | 6 | 0 up, 1 down | May 7, 2026 | $68.42M |
| Dec 31, 2025 | $0.45 | $0.45 | $0.31 - $0.52 | 0.00% | In line | +18.4% | 5 | 1 up, 2 down | Feb 26, 2026 | $92.92M |
| Sep 30, 2025 | $0.10 | -$0.01 | -$0.09 - $0.03 | N/A | N/A | N/A | 6 | 0 up, 3 down | Nov 6, 2025 | $67.50M |
| Jun 30, 2025 | -$0.01 | -$0.04 | -$0.08 - -$0.01 | +75.00% | Beat | N/A | 6 | 1 up, 1 down | Jul 31, 2025 | $63.24M |
| Mar 31, 2025 | -$0.23 | -$0.15 | -$0.25 - -$0.06 | -53.33% | Miss | N/A | 6 | 1 up, 1 down | May 8, 2025 | $52.60M |
| Dec 31, 2024 | $0.38 | $0.34 | $0.33 - $0.35 | +11.76% | Beat | +46.2% | 2 | 0 up, 1 down | Feb 27, 2025 | $75.38M |
| Sep 30, 2024 | -$0.02 | -$0.05 | -$0.08 - -$0.02 | +60.00% | Beat | N/A | 7 | 0 up, 0 down | Nov 7, 2024 | $57.91M |
| Jun 30, 2024 | -$0.10 | -$0.09 | -$0.15 - -$0.05 | -11.11% | Miss | N/A | 6 | 0 up, 0 down | Aug 1, 2024 | $52.66M |
| Mar 31, 2024 | -$0.08 | -$0.10 | -$0.17 - -$0.05 | +20.00% | Beat | N/A | 6 | 0 up, 0 down | May 8, 2024 | $51.28M |
| Dec 31, 2023 | $0.26 | $0.17 | $0.14 - $0.20 | +52.94% | Beat | +116.7% | 6 | 1 up, 0 down | Feb 29, 2024 | $65.00M |
| Sep 30, 2023 | -$0.05 | -$0.12 | -$0.14 - -$0.09 | +58.33% | Beat | N/A | 6 | 0 up, 0 down | Nov 8, 2023 | $45.58M |
| Jun 30, 2023 | -$0.11 | -$0.15 | -$0.18 - -$0.11 | +26.67% | Beat | N/A | 5 | 0 up, 0 down | Aug 2, 2023 | $45.92M |
| Mar 31, 2023 | -$0.16 | -$0.16 | -$0.18 - -$0.13 | 0.00% | In line | N/A | 5 | 0 up, 0 down | May 10, 2023 | $41.02M |
| Dec 31, 2022 | $0.12 | $0.04 | -$0.01 - $0.08 | +200.00% | Beat | +33.3% | 5 | 0 up, 0 down | Feb 23, 2023 | $52.69M |
| Sep 30, 2022 | -$0.14 | -$0.10 | -$0.13 - -$0.04 | -40.00% | Miss | N/A | 5 | 0 up, 0 down | Nov 9, 2022 | $38.55M |
| Jun 30, 2022 | -$0.19 | -$0.12 | -$0.14 - -$0.09 | -58.33% | Miss | N/A | 5 | 0 up, 0 down | Aug 3, 2022 | $37.05M |
| Mar 31, 2022 | -$0.15 | -$0.12 | -$0.31 - -$0.02 | -25.00% | Miss | N/A | 6 | 0 up, 0 down | May 4, 2022 | $36.07M |
| Dec 31, 2021 | $0.09 | $0.14 | $0.06 - $0.19 | -35.71% | Miss | -64.0% | 6 | 0 up, 0 down | Feb 24, 2022 | $47.59M |
| Sep 30, 2021 | -$0.11 | -$0.02 | -$0.05 - $0.01 | -450.00% | Miss | -237.5% | 8 | 1 up, 0 down | Nov 9, 2021 | $34.51M |
| Jun 30, 2021 | -$0.08 | -$0.09 | -$0.14 - -$0.03 | +11.11% | Beat | N/A | 8 | N/A | Aug 4, 2021 | $39.52M |
| Mar 31, 2021 | -$0.07 | -$0.04 | -$0.10 - $0.00 | -75.00% | Miss | N/A | 8 | N/A | May 5, 2021 | $34.57M |
| Dec 31, 2020 | $0.25 | $0.20 | $0.17 - $0.25 | +25.00% | Beat | +25.0% | 8 | N/A | Feb 24, 2021 | $45.23M |
| Sep 30, 2020 | $0.08 | -$0.02 | -$0.09 - $0.10 | +500.00% | Beat | +14.3% | 7 | N/A | Nov 5, 2020 | $32.26M |
| Jun 30, 2020 | -$0.18 | -$0.20 | -$0.26 - -$0.15 | +10.00% | Beat | N/A | 6 | N/A | Aug 5, 2020 | $20.01M |
| Mar 31, 2020 | -$0.10 | -$0.08 | -$0.12 - -$0.05 | -25.00% | Miss | N/A | 6 | N/A | May 5, 2020 | $26.68M |
| Dec 31, 2019 | $0.20 | $0.20 | $0.17 - $0.23 | 0.00% | In line | +53.8% | 6 | N/A | Feb 25, 2020 | $39.39M |
| Sep 30, 2019 | $0.07 | -$0.02 | -$0.04 - $0.01 | +450.00% | Beat | N/A | 6 | N/A | Nov 5, 2019 | $30.50M |
| Jun 30, 2019 | -$0.05 | -$0.06 | N/A | +16.67% | Beat | N/A | 4 | N/A | Aug 6, 2019 | $26.15M |
| Mar 31, 2019 | -$0.07 | -$0.07 | -$0.10 - -$0.02 | 0.00% | In line | N/A | 5 | N/A | May 7, 2019 | $21.81M |
| Dec 31, 2018 | $0.13 | $0.04 | $0.03 - $0.05 | +225.00% | Beat | +333.3% | 5 | N/A | Feb 26, 2019 | $31.34M |
| Sep 30, 2018 | -$0.02 | -$0.11 | -$0.13 - -$0.08 | +81.82% | Beat | N/A | 5 | N/A | Nov 6, 2018 | $22.48M |
| Jun 30, 2018 | -$0.12 | -$0.12 | -$0.13 - -$0.09 | 0.00% | In line | N/A | 5 | N/A | Aug 6, 2018 | $19.01M |
| Mar 31, 2018 | -$0.21 | -$0.13 | -$0.16 - -$0.11 | -61.54% | Miss | N/A | 5 | N/A | May 8, 2018 | $18.03M |
| Dec 31, 2017 | $0.03 | -$0.07 | -$0.10 - -$0.04 | +142.86% | Beat | N/A | 4 | N/A | Mar 5, 2018 | $23.35M |
| Sep 30, 2017 | -$0.13 | -$0.16 | N/A | +18.75% | Beat | N/A | N/A | N/A | Nov 7, 2017 | $14.26M |
| Jun 30, 2017 | -$0.07 | -$0.19 | N/A | +63.16% | Beat | N/A | N/A | N/A | Aug 9, 2017 | $16.95M |
| Mar 31, 2017 | -$0.31 | -$0.16 | N/A | -93.75% | Miss | N/A | N/A | N/A | May 10, 2017 | $9.36M |
| Dec 31, 2016 | -$0.23 | -$0.18 | N/A | -27.78% | Miss | N/A | N/A | N/A | Mar 10, 2017 | $16.52M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.31, up 72.2% from the year before. It was -$0.79 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.31 | +72.2% |
| Dec 31, 2024 | $0.18 | N/A |
| Dec 31, 2023 | -$0.06 | N/A |
| Dec 31, 2022 | -$0.36 | N/A |
| Dec 31, 2021 | -$0.17 | -440.0% |
| Dec 31, 2020 | $0.05 | -66.7% |
| Dec 31, 2019 | $0.15 | N/A |
| Dec 31, 2018 | -$0.22 | N/A |
| Dec 31, 2017 | -$0.48 | N/A |
| Dec 31, 2016 | -$0.79 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,900 words across 12 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,863 | 12 | |
| 2026Q1 | Mar 31, 2026 | 7,637 | 12 | |
| 2025Q4 | Dec 31, 2025 | 5,609 | 12 | |
| 2025Q3 | Sep 30, 2025 | 6,063 | 11 | |
| 2025Q2 | Jun 30, 2025 | 6,287 | 11 | |
| 2025Q1 | Mar 31, 2025 | 7,362 | 10 | |
| 2024Q4 | Dec 31, 2024 | 8,389 | 12 | |
| 2024Q3 | Sep 30, 2024 | 7,185 | 11 |
2026Q3 Earnings Call
Opening remarks
Eric Burns VP of Finance and Investor Relations Thank you, operator, and good morning, everyone. Joining me on today's call are Vericel's President and Chief Executive Officer, Nick Colangelo, and our Chief Financial Officer, Joe Mara. Before we begin, I would like to remind you that the discussions during this conference call will include forward-looking statements. Factors that could cause actual results to differ materially from expectations are discussed more fully in the company's most recent filings with the SEC. Also, the discussions today will include certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP financial measures can be found in today's press release, which is included as an exhibit to Vericel's current report on Form 8-K filed today with the SEC. A short presentation with highlights from today's call is also available in the Investor Relations section of our website. I will now turn the call over to Nick.
Nick Colangelo President and Chief Executive Officer Thank you, Eric, and good morning, everyone. The company had an outstanding third quarter, which was the strongest quarter of the year on a number of measures for the company, MACI, and our burn care business, as we generated top-tier revenue growth across the portfolio, an inflection in profitability, and significant free cash flow. We delivered record third quarter total revenue of more than $85 million, which increased 26% over last year and significantly exceeded our guidance for the quarter. Based on our third quarter outperformance and the strong momentum that has continued into the fourth quarter, we are raising our full-year total revenue guidance to $344 million-$346 million, which represents 25% revenue growth for the year at the midpoint and an increase in revenue guidance of nearly $25 million since the start of the year. We also had another excellent quarter from a profitability perspective, as net income nearly tripled, adjusted EBITDA grew nearly 50% to more than $25 million, and adjusted EBITDA margin increased to 30%, which was significantly higher than our guidance for the quarter. Based on this outperformance on profitability measures, we are also raising our adjusted EBITDA margin guidance for the year. MACI had another great quarter with record third quarter revenue of more than $67 million, which exceeded our guidance for the quarter and increased 21% versus the prior year, marking the sixth consecutive quarter with MACI revenue growth of 20% or more, which was notable given the significant acceleration in MACI implant and revenue growth in the third quarter of last year. Beyond MACI's strong revenue performance, we continue to see significant momentum in the underlying business fundamentals that support sustained MACI growth. We achieved record third quarter MACI biopsies, implants, and biopsy and implanting surgeons.
Frequently Asked Questions About VCEL
When is Vericel Corp Ord's next earnings date?
Vericel Corp Ord's next earnings report is expected for Feb 24, 2027.
What EPS do analysts expect from VCEL next quarter?
The consensus EPS estimate for Vericel Corp Ord for the quarter ending Dec 31, 2026 is $0.58 from 10 analysts, with estimates from $0.46 to $0.65.
How often does VCEL beat earnings estimates?
Vericel Corp Ord beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +38.42%.
VCEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors